ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
BCII Enterprises Inc (PK)

BCII Enterprises Inc (PK) (BCII)

0,01755
0,00165
(10,38%)
Geschlossen 04 Dezember 10:00PM

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Current Price
0,01755
Gebot
0,015
Fragen
0,0292
Volumen
1.264.076
0,0137 Tagesbereich 0,02
0,01025 52-Wochen-Bereich 0,0399
Marktkapitalisierung
Handelsende
0,0159
Handelsbeginn
0,014
Letzte Trade
141651
@
0.01755
Letzter Handelszeitpunkt
Finanzvolumen
US$ 21.573
VWAP
0,017066
Durchschnittliches Volumen (3 Mio.)
143.182
Ausgegebene Aktien
47.196.686
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-5,26
Gewinn pro Aktie (EPS)
-0
Erlöse
-
Nettogewinn
-177k

Über BCII Enterprises Inc (PK)

The Company, referred to as BCII, was formerly a shell. On December 15, 2021, BCIi completed the acquisition of 100% of the capital stock of NFT Clearing, Inc. pursuant to a Share Exchange Agreement. Additionally, on or about July 17, 2022, BCII purchased 100% of the capital stock of YourInfo.com Co... The Company, referred to as BCII, was formerly a shell. On December 15, 2021, BCIi completed the acquisition of 100% of the capital stock of NFT Clearing, Inc. pursuant to a Share Exchange Agreement. Additionally, on or about July 17, 2022, BCII purchased 100% of the capital stock of YourInfo.com Corp. In connection with its acquisitions of NFT Clearing on December 15, 2021, and YourInfo on July 17, 2022, and that during the period from January 2022 through October 2022, BCII received advances of approximately $520,000 to fund BCII's operations and that of its subsidiaries, including hiring consultants to provide bona fide services and since March 2022 received investments evidenced by software technology designed to enable users to download all the information that any website gathers on them such as Facebook, Google and Amazon, which was previously difficult to access, BCII ceased being a shell company and became a non-shell company effective on August 1, 2022.. YourInfo translates the information for individual users providing the technology they need to gather their data from Web 2.0 sites so that they can market that data for themselves, so as to act as the unique bridge to Web 3.0, NFT Clearing has teamed up with a regulated NFT exchange to allow the trading of the individual's unique key that advertisers will use to view the aforementioned data, which key will be auctioned off on the regulated NFT exchange. Mehr anzeigen

Sektor
Business Services, Nec
Branche
Business Services, Nec
Hauptsitz
Lewes, Delaware, USA
Gegründet
-
BCII Enterprises Inc (PK) is listed in the Business Services sector of the OTCMarkets with ticker BCII. The last closing price for BCII Enterprises (PK) was US$0,02. Over the last year, BCII Enterprises (PK) shares have traded in a share price range of US$ 0,01025 to US$ 0,0399.

BCII Enterprises (PK) currently has 47.196.686 shares in issue. The market capitalisation of BCII Enterprises (PK) is US$750.427,31 . BCII Enterprises (PK) has a price to earnings ratio (PE ratio) of -5.26.

BCII Neueste Nachrichten

ImmuDyne Announces Strategic Blockchain-Linked Investment

NEW YORK, Nov. 27, 2017 (GLOBE NEWSWIRE) -- ImmuDyne, Inc. (OTCQB:IMMD) (“ImmuDyne” or the “Company”), a leader in the development and online marketing of OTC health and wellness products...

Genzyme, Bone Care International Announce Shareholder Approval of Merger

Genzyme, Bone Care International Announce Shareholder Approval of Merger Acquisition to Strengthen Genzyme's Growing Renal Business CAMBRIDGE, Mass. and MIDDLETON, Wis., June 30...

Genzyme and Bone Care International Announce Completion of Hart-Scott-Rodino Review

Genzyme and Bone Care International Announce Completion of Hart-Scott-Rodino Review CAMBRIDGE, Mass. and MADISON, Wis., June 15 /PRNewswire-FirstCall/ -- Genzyme Corporation (NASDAQ:GENZ) and...

Bone Care International Announces Patent Issuance

Bone Care International Announces Patent Issuance Patent for Stabilized Hydroxyvitamin D2 Products Covers Hectorol(R) (doxercalciferol) MIDDLETON, Wis., June 7 /PRNewswire-FirstCall/ -- Bone...

Medicare Part D Coverage to Include D-Hormones

Medicare Part D Coverage to Include D-Hormones MIDDLETON, Wis., May 18 /PRNewswire-FirstCall/ -- Bone Care International, Inc. (NASDAQ:BCII) announces that the Centers for Medicare and...

Bone Care International Announces Advancement of LR-103 Into Human Patients With Stage 5 Chronic Kidney Disease

Bone Care International Announces Advancement of LR-103 Into Human Patients With Stage 5 Chronic Kidney Disease - New Vitamin D Hormone Replacement Therapy for Chronic Kidney Disease...

Genzyme and Bone Care International Announce Merger Agreement ------------------------------------------------------ Genzyme to

Genzyme and Bone Care International Announce Merger Agreement Genzyme to Acquire Bone Care, Adding Complementary Therapy to Renagel; Accelerates Commercial Entry into Earlier Stages of Chronic...

Bone Care International, Inc. Reports Third Quarter FY 2005 Financial Results

Bone Care International, Inc. Reports Third Quarter FY 2005 Financial Results - Quarterly Hectorol(R) Sales of $22.0 Million, 89% Increase - MIDDLETON, Wis., April 26 /PRNewswire-FirstCall/...

Bone Care International Names Charles W. Bishop, Ph.D., as Executive Vice President and Chief Scientific Officer

Bone Care International Names Charles W. Bishop, Ph.D., as Executive Vice President and Chief Scientific Officer MIDDLETON, Wis., April 25 /PRNewswire-FirstCall/ -- Bone Care International, Inc...

Bone Care International to Present at Deutsche Bank Health Care Conference

Bone Care International to Present at Deutsche Bank Health Care Conference MIDDLETON, Wis., April 22 /PRNewswire-FirstCall/ -- Bone Care International, Inc. (NASDAQ:BCII) today announced that...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.0028519.3877551020.01470.020.0117302590.01480741CS
40.00312521.66377816290.0144250.020.010853131770.01507728CS
12-0.00125-6.648936170210.01880.020.010251431820.0147846CS
260.001559.68750.0160.0350.010251038260.01742728CS
52-0.00645-26.8750.0240.03990.01025770650.01959196CS
156-0.20245-92.02272727270.220.30.01025485020.06252567CS
260-0.88245-98.050.990.01025783920.39987129CS
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
AOLSAeolus Pharmaceuticals Inc (CE)
US$ 0,005
(499.900,00%)
385
IPTKAS IP Tech Inc (CE)
US$ 0,0018
(179.900,00%)
1.000
ASRHFAstroscale Holdings Inc (PK)
US$ 5,40
(107.900,00%)
9,2k
VIVEViveve Medical Inc (CE)
US$ 0,0005
(49.900,00%)
23,11k
IDBHFIndustrias Bachoco SAB De CV (CE)
US$ 0,0161
(16.000,00%)
600
FDVXFFenixOro Gold Corporation (CE)
US$ 0,000001
(-100,00%)
6k
PLBLFAltus Copper Corporation (CE)
US$ 0,000001
(-99,93%)
100
EGSEEvergreen Sustainable Enterprises Inc (CE)
US$ 0,000001
(-99,86%)
1.000
BZTGBuzz Technologies Inc (CE)
US$ 0,000001
(-99,80%)
2,58M
ARBHArboreta Healthcare Inc (CE)
US$ 0,000001
(-99,67%)
2k
HMBLHUMBL Inc (PK)
US$ 0,0006
(100,00%)
1,29B
FUNRFunr (PK)
US$ 0,0004
(300,00%)
176,72M
RDARRaadr Inc (PK)
US$ 0,001025
(-6,82%)
154,48M
TSOITherapeutic Solutions International Inc (PK)
US$ 0,0005
(11,11%)
138,82M
THBDThird Bench Inc (PK)
US$ 0,0001
(0,00%)
112,68M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock